INDACATEROL: 1,765 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
1,765
Total FAERS Reports
349 (19.8%)
Deaths Reported
723
Hospitalizations
1,765
As Primary/Secondary Suspect
64
Life-Threatening
24
Disabilities
Jul 1, 2011
FDA Approved
Discontinued
Status
FDA Application: 022383 ·
Patent Expires: Oct 11, 2028 · First Report: 2008 · Latest Report: 20240723
What Are the Most Common INDACATEROL Side Effects?
#1 Most Reported
Dyspnoea
489 reports (27.7%)
#2 Most Reported
Asthma
232 reports (13.1%)
#3 Most Reported
Cough
223 reports (12.6%)
All INDACATEROL Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 489 | 27.7% | 44 | 265 |
| Asthma | 232 | 13.1% | 5 | 141 |
| Cough | 223 | 12.6% | 10 | 67 |
| Pneumonia | 201 | 11.4% | 36 | 103 |
| Malaise | 163 | 9.2% | 16 | 91 |
| Wheezing | 161 | 9.1% | 3 | 136 |
| Death | 144 | 8.2% | 144 | 10 |
| Chronic obstructive pulmonary disease | 137 | 7.8% | 23 | 93 |
| Drug ineffective | 125 | 7.1% | 4 | 25 |
| Condition aggravated | 121 | 6.9% | 8 | 48 |
| Fall | 120 | 6.8% | 4 | 93 |
| Weight decreased | 120 | 6.8% | 10 | 38 |
| Blood pressure increased | 111 | 6.3% | 1 | 88 |
| General physical health deterioration | 103 | 5.8% | 11 | 90 |
| Therapeutic product effect incomplete | 102 | 5.8% | 0 | 99 |
| Product use issue | 100 | 5.7% | 18 | 38 |
| Fatigue | 97 | 5.5% | 7 | 50 |
| Hypertension | 97 | 5.5% | 5 | 24 |
| Bronchospasm | 95 | 5.4% | 1 | 77 |
| Pain | 93 | 5.3% | 2 | 74 |
Who Reports INDACATEROL Side Effects? Age & Gender Data
Gender: 49.9% female, 50.1% male. Average age: 68.7 years. Most reports from: COUNTRY NOT SPECIFIED. View detailed demographics →
Is INDACATEROL Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2008 | 1 | 0 | 0 |
| 2009 | 2 | 0 | 0 |
| 2010 | 2 | 1 | 0 |
| 2011 | 17 | 0 | 9 |
| 2012 | 24 | 6 | 9 |
| 2013 | 83 | 20 | 45 |
| 2014 | 158 | 33 | 77 |
| 2015 | 134 | 27 | 72 |
| 2016 | 109 | 26 | 41 |
| 2017 | 83 | 17 | 42 |
| 2018 | 46 | 14 | 19 |
| 2019 | 35 | 7 | 13 |
| 2020 | 41 | 6 | 8 |
| 2021 | 16 | 4 | 9 |
| 2022 | 19 | 1 | 12 |
| 2023 | 10 | 0 | 3 |
| 2024 | 19 | 0 | 18 |
What Is INDACATEROL Used For?
| Indication | Reports |
|---|---|
| Chronic obstructive pulmonary disease | 676 |
| Product used for unknown indication | 607 |
| Emphysema | 153 |
| Asthma | 132 |
| Lung disorder | 67 |
| Dyspnoea | 53 |
| Off label use | 26 |
| Respiratory disorder | 15 |
| Bronchitis chronic | 12 |
| Bronchitis | 10 |
INDACATEROL vs Alternatives: Which Is Safer?
INDACATEROL vs INDAPAMIDE
INDACATEROL vs INDAPAMIDE\PERINDOPRIL
INDACATEROL vs INDAPAMIDE\PERINDOPRIL ARGININE
INDACATEROL vs INDAPAMIDE\PERINDOPRIL ERBUMINE
INDACATEROL vs INDINAVIR
INDACATEROL vs INDOMETHACIN
INDACATEROL vs INDOMETHACIN\INDOMETHACIN
INDACATEROL vs INEBILIZUMAB-CDON
INDACATEROL vs INEXIUM
INDACATEROL vs INFLIXIMAB
Official FDA Label for INDACATEROL
Official prescribing information from the FDA-approved drug label.